Cicatricial Alopecia as a Manifestation of Different Dermatoses by Lenka Oremović et al.
246
Cicatricial Alopecia as a Manifestation of Different 
Dermatoses
Lenka Oremović1, Liborija Lugović1, Majda Vučić2, Marija Buljan1, Suzana 
Ožanić-Bulić1 
1University Department of Dermatology and Venereology; 2Department of Pathology, 
Sestre milosrdnice University Hospital, Zagreb, Croatia
Corresponding author:
Liborija Lugović, MD, PhD
University Department of Dermatology and Venereology 





Received: September 22, 2006
Accepted: October 30, 2006
SUMMARY There are numerous dermatoses which may 
cause cicatricial alopecia when localized on the scalp, 
such as chronic discoid lupus erythematosus (DLE), li-
chen planus, graft-versus-host disease, dermatomyositis, 
scleroderma, cicatricial pemphigoid, porphyria cutanea 
tarda, follicular mucinosis, perifolliculitis capitis absce-
dens, lichen sclerosus et atrophicus, necrobiosis lipoidica, 
sarcoidosis, etc. Histologically, cicatricial alopecia is char-
acterized by dermal scarring, along with absent or reduced 
hair follicles and reduced number of erector pili muscles. 
According to working classification of cicatricial alopecia 
by the North American Hair Society, primary cicatricial 
alopecia may be divided into the following categories: 
lymphocytic group (e.g., DLE, lichen planopilaris, classic 
pseudopelade (Brocq), central centrifugal cicatricial alope-
cia); neutrophilic group (e.g., folliculitis decalvans, dissect-
ing cellulitis); and mixed group (e.g., folliculitis keloidalis). 
Over a 5-year period, 36 patients with cicatricial alopecia 
were hospitalized at our Department: DLE (n=27), pseudo-
pelade Brocq (n=3), mucinosis follicularis (n=2), and lichen 
planopilaris, folliculitis decalvans, folliculitis abscedens and 
folliculitis keloidalis (one patient each). Clinical evaluation 
was compared with histopathologic analysis of follicular ar-
chitecture, as well as with the type, localization and extent 
of inflammatory infiltrate. Scalp biopsy was considered 
mandatory in all cases. Our experience indicates the need 
of more complex research to extend the knowledge about 
the etiopathogenesis and treatment options for cicatricial 
alopecia. We hope that this type of alopecia may attract 
more attention and research in the future.
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INTRODUCTION 
 Besides noncicatricial (nonscarring) forms, 
there is “scarring” (cicatricial) alopecia where fol-
licular epithelium is replaced by connective tissue, 
leading to an irreversible process of scarring (1). 
Primary cicatricial alopecias encompass a group 
of disorders characterized by permanent destruc-
tion of the hair follicle (2). They include destruc-
tion of the hair follicle with inflammatory process 
predominantly around the permanent portion of 
the hair follicle (stem cells of the bulge and the 
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infundibulum), hence resulting in irreversibility of 
alopecia (3-6). 
 The various clinical features and differences in 
terminology have led to difficulties in defining con-
sistent clinicopathologic correlation (2). There are 
a series of dermatoses which may cause cicatri-
cial alopecia when localized on the scalp, such as 
chronic discoid lupus erythematosus (DLE), lichen 
planus (LP), graft-versus-host disease (GVHD), 
dermatomyositis (in its chronic, poikilodermic 
phase), scleroderma (especially in the en coup 
de sabre form), cicatricial pemphigoid, porphyria 
cutanea tarda, perifolliculitis capitis abscedens, 
lichen sclerosus et atrophicus, necrobiosis lipoidi-
ca, sarcoidosis, follicular mucinosis, etc. (3,7,8).
 Histologically, cicatricial alopecia is charac-
terized by dermal scarring, often relatively deep, 
along with absent or reduced hair follicles and re-
duced number of erector pili muscles. They rep-
resent a diverse group of diseases characterized 
by the lack of follicular ostia and irreversible alope-
cia. Currently, various classification schemes are 
availalable for cicatricial alopecias. Thus, cicatricial 
alopecias may be clasified into congenital cicatri-
cial alopecias (genodermatoses: Darier’s disease, 
sex linked ichthyosis, dystrophic epidermolysis 
bullosa, incontinentia pigmenti, polyostotic fibrous 
displasia, HHHH syndrome (hypotrichia, hyper-
keratosis, hydrocystomas, hypodontia), obstetric 
traumas, nevi (organoid and epidermal), simplex 
hereditary hypotrichoses, follicular keratosis, apla-
sia cutis congenita, etc. 
 Another group of cicatricial alopecia are ac-
quired cicatricial alopecias. This type of alopecia 
may be the result of physical traumas (chronic trac-
tion, avulsion, electrical or thermal burns, freezing, 
ionizing radiation, neurotrophic ulcers), chemical 
traumas (alcali, acids), cutaneous infections (fun-
gal, viral, bacterial, zooparasitoses), or tumors 
(benign, malignant). Acquired cicatricial alopecias 
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Figure 1. Lupus erythematosus chronicus: hyperkeratosis, dillated follicular ostia filled with keratine, 
liquefaction degeneration of basal keratinocytes, incontinentia pigmenti, predominantly lymphocytic 
infiltration at the dermal-epidermal border as well as pericapillary and periadnexal
Figure 2. Lichen planopilaris: follicular hyperkeratosis and dillated follicular ostia, typical lichenoid 
striped infiltration which erodes basal layers of the epidermis, incontinentia pigmenti
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also include aquired cicatricial alopecias in special 
dermatoses (primary cicatricial alopecia), such as 
DLE, LP, GVHD, sarcoidosis, linear morphea, por-
phyrinic alopecia, perifolliculitis capitis abscedens 
et suffodiens, mucinosis follicularis, pseudopelade 
Brocq, Pinku’s fibrosing alopecia, erosive pustular 
dermatosis of the scalp, etc. 
 Currently, there is also a classification scheme 
of cicatricial alopecias according to the North 
American Hair Sociaty (NAHRS) (7). According 
to the working classification of cicatricial alope-
cia, primary cicatricial alopecia can be divided into 
the following categories: lymphocytic group (e.g., 
DLE, lichen planopilaris (LPP), classic pseudope-
lade (Brocq), central centrifugal cicatricial alope-
cia); neutrophilic group (e.g., folliculitis decalvans, 
dissecting cellulitis); and mixed group (e.g., follicu-
litis keloidalis). There is also a group of nonspe-
cific cicatricial alopecia, defined as an idiopathic 
scarring alopecia with inconclusive clinical and 
histopathologic findings (7).
 The aim of this study was to determine the 
causes of scarring alopecia by clinical and histo-
pathologic characteristics in patients hospitalized 
at our Department during a 5-year period.
PATIENTS AND METHODS
 The study was conducted at University Depart-
ment of Dermatology and Venereology, Sestre mi-
losrdnice University Hospital, Zagreb, Croatia. The 
patients with scarring alopecia were monitored 
over a 5-year period (2001-2005). We performed 
prospective clinical and histopathologic evaluation 
of clinically typical primary cicatricial alopecias. Bi-
opsy specimens were obtained from early stages 
of alopecia lesions.
 Over the 5-year period, 36 patients with cicatri-
cial alopecia were hospitalized at our Department 
(Table 1). A total of 36 patients with cicatricial alo-
pecia were included in the study. The examina-
tion included history data, duration of the disease, 
previous treatment, trichogram, antinuclear an-
tibodies, histopathologic analysis, and direct im-
munoflurescence. The diagnoses were set upon 
analysis of these data. 
RESULTS
 Over the 5-year period, we treated 36 patients 
with cicatricial alopecia by the previously men-
tioned procedures: DLE (n=27), pseudopelade 
Brocq (n=3), mucinosis follicularis (n=2), lichen 
planopilaris (n=3), and folliculitis decalvans, fol-
liculitis abscedens and folliculitis keloidalis (one 
patient each) (Table 1). Thus, most of our patients 
had DLE (n=27), followed by pseudopelade Brocq 
(n=3) and mucinosis follicularis (n=2). Results 
of clinical and histopathologic examinations are 
shown in Figures 1-6. Patients were treated ac-
cording to recommendations for the respective 
histologic type of alopecia (Table 2).
DISCUSSION
 The term cicatricial alopecia represents a 
group of disorders characterized by the final path-
way of replacement of the follicular structure by 
fibrous tissue (9). In dermatological practice, the 
term cicatricial alopecia is considered convenient 
because it is clear from the beginning that there 
 















Table 1. Distribution of alopecia areata in our patients according to histopathological findings






chronicus 27/75 19:8 20-70 49,9
Lichen planopilaris 1/2,8 F 31
Pseudopelade 3/8,3 F  40-54 49,3
NEUTROPHILIC
Folliculitis decalvans 1 / 2,8 M 24
Folliculitis abscendens 1/2,8 M 20
MIXED Folliculitis keloidalis 1 / 2,8 M 37
MUCINOUS/CICATRICIAL Follicular mucinosis 2/5,5 1:1 42,57 49,5
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are no follicles, as they have been replaced by 
fibrosed or slack dermal tissue (3). There are dif-
ferent hypotheses based on the etiological factors 
involved in the development of cicatricial alopecia 
(9). It has been suggested that cicatricial alopecias 
have a genetic component (predisposion), but en-
viromental factors also play a role in its develop-
ment, including chemical contributions and infec-
tive factors (viral, bacterial, fungal). Experimental 
studies have also confirmed cicatricial alopecias in 
laboratory mice (spontaneous or induced), similar 
to that seen in humans. There is some evidence 
that cicatricial alopecia results from a defect in the 
hair follicle structural proteins or an abnormal im-
mune response. There are also some arguments 
indicating that cicatricial alopecia is a secondary 
result of pathologic fragments of follicle-nutrient 
vessels and/or nerves, or the result of disruption 
in the mesenchymal/epithelial interactions which 
are nececessary for normal cycling (9). However, 
these etiologic factors have not yet been elucidat-
ed and need to be tested, confirmed or excluded 
in the future.
 Besides primary cicatricial alopecias, there are 
several causes of secondary cicatricial alopecia 
such as certain types of dermatophyte infections, 
infiltrative processes (e.g., metastatic cancers), 
and trauma (e.g., radiation or burns). There are 
Figure 3. Pseudopelade Brocq: extensive lymphocytic perifollicular infiltration leading to the replacement 
of follicle with the fibrous streak
Figure 4. Folliculitis decalvans: destructive chronic or subacute folliculitis with perifollicular chronic 
inflammatory cells
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many other environmental factors suspected of 
invoking or contributing to the development of 
permanent alopecia, such as chemicals used to 
straighten or curl hair in selected susceptible pop-
ulations (9). The classification of primary cicatri-
cial alopecias on the basis of pathology provides 
further diagnostic and investigational procedures 
(10).
 However, most of our patients with cicatricial 
alopecias were those with DLE. In chronic DLE, 
cicatricial alopecia is the result of chronic inflam-
matory infiltrate which destroys the follicle and 
cutaneous adnexa. It is present in the form of sin-
gle or multiple patches of variable size, with pig-
mented periphery and atrophic central skin, which 
tends to grow slowly. It has been noticed that 35% 
of DLE patients have cicatricial alopecias, long-
standing DLE in almost all of them (11). One can 
also find this type of alopecia in systemic LE (11). 
Histologically, there is a reduction in the size of 
sebaceous glands with perifollicular lymphocytic 
infiltrate, which is more obvious in the middle por-
tion at the level of sebaceous gland (12). Classic 
treatment includes topical fluoridated corticoste-
roids, systemic or intralesional corticosteroids, but 
antimalarial drugs and sulfones may be effective 
as well. Recently, it has been reported that the use 
of thalidomide in this process may result in regres-
sion of alopecic patches on the scalp (13). Pseu-
dopelade is non-inflammatory progressive and id-
iopathic cicatricial alopecia, which is characterized 
by small erythematous alopecic areas located on 
the scalp tending to confluence. Thus, a larger al-
opecic patch with dentated edges is formed, with 
some centrally dispersed hairs, occasionally with 
true retractile follicular depressions and intact pe-
ripheral hair implantion line (13,14).
 Follicular mucinosis (alopecia mucinosa) is 
characterized by very pruriginous infiltrated ery-
Figure 5. Folliculitis abscendens: destructive acute folliculitis with neutrophils and suppuration
Figure 6. Follicular mucinosis: pilosebaceous degeneration associated with the deposites of mucine I, 
with inflammatory infiltrates and histiocytes, and variable number of eosinophils
Oremović et al.    Acta Dermatovenerol Croat
Cicatricial alopecia      2006;14(4):246-252
ACTA DERMATOVENEROLOGICA CROATICA
251
thematosquamous patches, consisting of a group 
of follicular papules, localized on the face, shoul-
ders, neck and scalp, and causing definite alope-
cia (3). In approximately 20% of cases it accompa-
nies mycosis fungoides, considered to be an early 
stage of mycosis fungoides in elderly people (15). 
A linear form of mucinosis follicularis has been de-
scribed on the scalp, following Blasckho’s lines, 
associated with lichen striatus, a process in which 
one can see follicular mucinosis (16). Dermatopa-
thologically, one can see mucine in the outer root 
sheath as well as in sebaceous glands.
 Scalp involvement within LP leads to an inflam-
matory process with characteristic erythematous 
inflitrates around the follicular openings associat-
ed with scarring alopecia, lichen planopilaris (3,8). 
The cutaneous features are typical and therefore 
easy to diagnose clinically and dermatopathologi-
cally, but only in the early stages of the diseases.
Other rarer cases of cicatricial alopecias in our 
patients included folliculitis, such as folliculitis de-
calvans, folliculitis abscedens and folliculitis keloi-
dalis.
 We consider that in patients with cicatricial 
alopecias it is important to examine clinical and 
pathologic features along with therapeutic options 
for the disease (10). It is very useful to perform 
histopathologic analysis of follicular architecture, 
type, location, and extent of the inflammatory infil-
trate, as well as the presence or absence of seba-
ceous glands (2). It is also important to distinguish 
the role of pathological findings of cicatricial alo-
pecias, the histological type of cicatricial alopecia 
(lymhocytic or neutrophilic) in particular, which has 
great influence on therapy. Analyzing the types 
of cicatricial alopecia among our patients, we 
found a greater proportion of lymhocytic cicatricial 
alopecias versus neutrophilic cicatricial alopecias, 
which is consistent with the data from the UBC 
Hair Clinic and results of Whiting (he found a pro-
portion of 4:1 (4,7). 
 There is a variety of therapeutic modalities for 
patients with lymphocytic cicatricial alopecias (7). 
These include potent topical (class I or II), intral-
esional or oral corticosteroids; antimalarials (clo-
roquine or hydroxychloroquine); and isotretionin. 
In our study, the patients were mostly treated with 
potent topical and/or intralesional corticosteroids 
(triamcinolone acetonide). The patients with ac-
tive disease or rapid progression may be treated 
by systemic corticosteroids (prednisone, initial 
dose of 1 mg/kg with gradual tapering over 6 to 8 
weeks). Intermittent short courses of prednisone 
were frequently required to control acute flares 
of both LE and LPP (7). Steroids are frequently 
combined with other systemic agents to achieve 
remission.
 Generally, the treatment of neutrophilic cicatri-
cial alopecia includes broad-spectrum antibiotics 
(tetracyclines, minocycline, cloxacillin, erythro-
mycin, or broad-spectrum cephalosporin) as first 
choice therapy. Frequently intralesional/potent 
corticosteroids may be added to curb acute in-
flammation (7).
CONCLUSION
 The high variability in the clinical presentation 
of cicatricial alopecias makes the diagnosis and 
treatment a challening issue in everyday derma-
tological practice. An accurate diagnosis may be 
achieved through attentive clinicopathologic eval-
uation with histopathologic analysis of follicular ar-
chitecture and changes of sebaceous glands, and 
type, location and extent of the inflammatory infil-
trate. We consider scalp biopsy mandatory in all 
cases. Our experience indicates the need of more 
complex research to extend the knowledge about 
the etiopathogenesis and treatment possibilities 
in cicatricial alopecia. We hope that this type of 
alopecia may attract more attention and research 
efforts in the future.
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